Operating Income: The income after operating expenses.
Cidara Therapeutics, Inc. (CDTX) had Operating Income of $-52.03M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$-7.49M |
|
$-52.31M |
|
-- |
|
$-7.49M |
|
$44.54M |
|
|
Operating Income |
$-52.03M |
$1.81M |
|
$-50.22M |
|
$-50.22M |
|
$-50.22M |
|
$-50.22M |
|
$-52.31M |
|
$-50.22M |
|
$-52.03M |
|
$-51.97M |
|
6.35M |
|
6.35M |
|
$-2.03 |
|
$-2.03 |
|
| Balance Sheet Financials | |
$210.74M |
|
$0.52M |
|
$4.06M |
|
$214.80M |
|
$49.55M |
|
-- |
|
$1.93M |
|
$51.49M |
|
$163.31M |
|
$163.31M |
|
$163.31M |
|
10.95M |
|
| Cash Flow Statement Financials | |
$-176.53M |
|
$-0.13M |
|
$337.06M |
|
$35.78M |
|
$196.18M |
|
$160.40M |
|
$3.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.25 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
79.13% |
|
694.70% |
|
694.70% |
|
-- |
|
670.49% |
|
698.36% |
|
$-176.66M |
|
-- |
|
-- |
|
-- |
|
-0.03 |
|
-- |
|
-4.42 |
|
-20.36 |
|
-30.75% |
|
-30.75% |
|
-23.38% |
|
-30.75% |
|
$14.92 |
|
$-27.82 |
|
$-27.80 |
|